Document Detail

Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
MedLine Citation:
PMID:  8044345     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The pathophysiology of plasma lipoprotein metabolism has long been linked to coronary artery disease (CAD). The present study evaluated the association between plasma lipoprotein lipid and apolipoprotein (apo) components and CAD in a group of 80 consecutive Caucasian patients undergoing coronary angiography. METHODS: Coronary cineangiography was carried out using the Judkins technique and the lesions quantified by calculating a coronary artery lesion score (CALS). Very low- and low-density lipoproteins (VLDL and LDL) were separated by ultracentrifugation, and high-density lipoprotein (HDL) and HDL subfraction-3 (HDL3) isolated by a differential precipitation procedure. Apo A-I, A-II, and B were assayed by endpoint laser nephelometry using specific antibodies. Total cholesterol, free cholesterol, and fatty acid concentrations were measured by gas-liquid chromatography, and lecithin: cholesterol acyltransferase (LCAT) activity by the decrease in the concentration of free cholesterol. RESULTS: On the basis of the presence of CAD, the 80 patients were divided into two groups: 52 (65%) with CAD (mean CALS = 7.8) and 28 (35%) without CAD (zero CALS). The lipoprotein fraction that most clearly differentiated the groups was HDL cholesterol concentration, with a mean +/- SEM value of 36.5 +/- 1.5 mg/dl for those with CAD and 45.1 +/- 2.1 mg/dl for those without (P < 0.01). The mean HDL3 cholesterol concentration was 29.9 +/- 1.2 mg/dl for patients with CAD and 37.4 +/- 1.8 mg/dl for those without (P < 0.001). These differences in HDL cholesterol and HDL3 cholesterol were mainly caused by differences in the free cholesterol component, with a mean HDL free cholesterol level of 10.8 +/- 1.1 and 16.1 +/- 1.4 mg/dl (P < 0.01), and a mean HDL3 free cholesterol level of 7.6 +/- 0.6 and 11.9 +/- 0.8 mg/dl (P < 0.001) in patients with and without CAD, respectively. Plasma LCAT activity was decreased in patients with CAD (P < 0.05), as were the apo A-I and A-II concentrations in both the HDL (P < 0.001) and HDL3 (P < 0.001) fractions. No significant association was found between CAD and HDL2 cholesterol or plasma total cholesterol, LDL cholesterol, or VLDL cholesterol concentrations. A stepwise discriminant analysis revealed that HDL3 free cholesterol was the only variable selected. Using HDL3 free cholesterol as a screening variable for CAD (cutoff 10.55 mg/dl), the sensitivity for CAD was 87% and the specificity for non-CAD 67%. The positive and negative predictive values of HDL3 free cholesterol were 82 and 75%, respectively. CONCLUSION: We have shown that the concentrations of HDL cholesterol and HDL3 most clearly differentiated between patients with and without CAD.
C M Smuts; H F Weich; M J Weight; M Faber; M Kruger; C J Lombard; A J Benadé
Related Documents :
12371975 - Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, ...
1514505 - Efficacy of lipid profiles in prediction of coronary disease.
25253805 - Dietary energy sources affect the partition of body lipids and the hierarchy of energy ...
17014005 - Modest but sustained increase of serum high density lipoprotein cholesterol levels in p...
3398075 - Female reproduction and pup survival and growth for mice fed a cadmium-containing purif...
22060995 - Growth performance and fatty acid profiles of intramuscular and subcutaneous fat from l...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Coronary artery disease     Volume:  5     ISSN:  0954-6928     ISO Abbreviation:  Coron. Artery Dis.     Publication Date:  1994 Apr 
Date Detail:
Created Date:  1994-08-31     Completed Date:  1994-08-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9011445     Medline TA:  Coron Artery Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  331-8     Citation Subset:  IM    
National Research Programme for Nutritional Intervention, South Africa Medical Research Council, Tygerberg.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apolipoproteins / analysis*
Biological Markers / blood
Cholesterol, HDL / blood*
Cholesterol, LDL / blood
Cholesterol, VLDL / blood
Coronary Angiography
Coronary Disease / blood*,  radiography
Lipoproteins, HDL / blood*
Middle Aged
Risk Factors
Sensitivity and Specificity
Reg. No./Substance:
0/Apolipoproteins; 0/Biological Markers; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Cholesterol, VLDL; 0/Lipoproteins, HDL

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Facilitation of coronary spasm by propranolol in Prinzmetal's angina: fact or unproven extrapolation...
Next Document:  Clinical significance of coronary flow reserve: effect of papaverine and exercise.